Beilage 1: Arzneimittelmonographien

First Page		Document Content
Date: 2007-11-25 08:41:46 Pharmacokinetics Immunosuppressants Lactones Morpholines Mycophenolic acid Phenols Prodrug Medroxyprogesterone Inosine MMF		Beilage 1: Arzneimittelmonographien Add to Reading List Source URL: www.sscc.ch Download Document from Source Website File Size: 40,92 KB Share Document on Facebook

	TECHNOLOGY OFFER www.wtz-ost.at NOVEL OXALIPLATIN PRODRUG A set of novel platinum (IV) oxaliplatin derivatives that are tumour-targeted through albumin binding have been synthesized and tested by collaborating DocID: 1ra9w - View Document
	Beilage 1: Arzneimittelmonographien DocID: 1p5Oy - View Document
	DNA repair processes involved with the hypoxia-activated prodrug evofosfamide (TH-302): comparison to cisplatin and temozolomideFanying Meng, Deepthi Bhupathi, Charles P. Hart DocID: 1ddQs - View Document
	Phase 1 Study of TH-302, a Hypoxia Activated Cytotoxic Prodrug, in Subjects with Advanced Leukemias DocID: 1cThC - View Document
	Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302 DocID: 1bCHv - View Document